Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02628132
Brief Title: Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients

First Submitted : November 29, 2015
First Submitted that Met QC Criteria : December 8, 2015
First Posted : December 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : March 29, 2018
Last Update Posted : March 30, 2018